DrugPatentWatch Database Preview
DARZALEX Drug Profile
Summary for Tradename: DARZALEX
| Patents: | 5 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for DARZALEX
| Ingredient-type | Antibodies, Monoclonal |
| Mechanism of Action | CD38-directed Antibody Interactions |
US Patents for DARZALEX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Biotech | DARZALEX | daratumumab | INJECTABLE;INJECTION | 761036 | 002 | 2015-11-16 | ➤ Try a Free Trial | ABBVIE STEMCENTRX LLC (North Chicago, IL) | ➤ Try a Free Trial | RX | Orphan | search |
| Janssen Biotech | DARZALEX | daratumumab | INJECTABLE;INJECTION | 761036 | 002 | 2015-11-16 | ➤ Try a Free Trial | Excelse Bio, Inc. (Thousand Oaks, CA) | ➤ Try a Free Trial | RX | Orphan | search |
| Janssen Biotech | DARZALEX | daratumumab | INJECTABLE;INJECTION | 761036 | 002 | 2015-11-16 | ➤ Try a Free Trial | The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) Janssen Biotech, Inc. (Spring House, PA) | ➤ Try a Free Trial | RX | Orphan | search |
| Janssen Biotech | DARZALEX | daratumumab | INJECTABLE;INJECTION | 761036 | 002 | 2015-11-16 | ➤ Try a Free Trial | Advenchen Pharmaceuticals, LLC (Moorpark, CA) | ➤ Try a Free Trial | RX | Orphan | search |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for DARZALEX
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Mexico | 2014005106 | ➤ Try a Free Trial |
| Hong Kong | 1218930 | ➤ Try a Free Trial |
| European Patent Office | 3291814 | ➤ Try a Free Trial |
| Australia | 2012328524 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
